fda warning peptides bpc-157 safety unapproved Regeneration or Risk? A Narrative Review of for Musculoskeletal Healing FDA Moves to Reevaluate Several
Description
Int Immunopharmacol (2019) 71:198204

Levels of Glutathione decrease as a result of aging, stress, and toxin exposure

I agree

sounds like you have found your path now and are in a better place

The committees review cited inadequate physicochemical characterization, immunogenicity and impurity concerns, and a lack of clinical effectiveness data a clear signal of continued regulatory caution about compounded AOD-9604 products
